Navigation Links
JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
Date:1/9/2009

OAK BROOK, Ill. and BATESVILLE, Ind., Jan. 9 /PRNewswire-FirstCall/ -- Recognizing the important role nurses play in translating evidence-based findings to excellent care at the patient's bedside, Joint Commission Resources (JCR) and Hill-Rom (NYSE: HRC), are collaborating to launch a Nurse Safety Scholar-in-Residence program in 2009. JCR is a not-for-profit affiliate of The Joint Commission. Hill-Rom is a global medical technology company.

The Nurse Safety Scholar-in-Residence program will focus initially on developing tools and best practices to maintain skin integrity and prevent pressure ulcers. An estimated 2.5 million patients are treated for pressure ulcers in acute care facilities in the United States each year, according to studies published in the Journal of the American Medical Association in 2003 and 2006. In the future, expert nurse clinicians and scholars in the program will concentrate on putting into practice evidence-based solutions to prevent patient falls. Both pressure ulcers and in-hospital falls are among the preventable conditions and events on Medicare's "no pay" list.

"Nurses play a role in all patient safety efforts and this scholar-in- residence program will give nursing leaders an opportunity to develop and share innovative solutions to these significant patient safety problems," says Deborah Nadzam, Ph.D., F.A.A.N., practice leader, Patient Safety, JCR.

"At Hill-Rom we strive to use our resources in ways that make a difference every day in the lives of patients and their caregivers," says Melissa Fitzpatrick, R.N., M.S.N., F.A.A.N., vice president and chief clinical officer for Hill-Rom. "We see collaborating with JCR in this important research as one key way to support the discovery of new solutions to truly enhance the safety and ultimate positive outcomes for patients.
'/>"/>

SOURCE Hill-Rom
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hill-Rom Announces First Quarter 2009 Dividend
2. Hill-Rom Wins Gold Brandon Hall Learning Award
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
4. Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames
5. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
6. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast
7. Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities
8. Hill-Rom to Present at the Jefferies Healthcare Conference
9. Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
10. Hill-Rom Announces Third Quarter 2008 Dividend
11. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 27, 2014 This is a ... Insulin industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry covers information on policy, plans for ... structure and much more. , This ...
(Date:11/27/2014)... At The Little Gym, we know that ... no surprise when a recent study confirmed that regular ... Journal of Pediatrics found that “Promoting physical ... the school years may be important not only for ... monitored two groups of children; those that were engaging ...
(Date:11/27/2014)... November 27, 2014 The Emerald Cup ... Up-Close Look At This Year’s Entries | SKUNK Magazine ... Stay For Two At Their Resort, Pure Garden, In ... or L.A.-based Hempcon, The Emerald Cup is presented by ... draws much of California’s original cannabis industry." – SFGate, ...
(Date:11/27/2014)... 27, 2014 In addition to a ... important gift home this holiday season and become educated ... Visiting with relatives over the holidays may raise questions ... Although some change in cognitive ability can occur with ... normal aging. Recognizing the difference between normal aging and ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... cardiovascular disease can all cloud symptoms, study says , , WEDNESDAY, ... (MS) may be delayed in people if they have other ... high blood pressure and high cholesterol appeared to mask early ... concluded the study, published in the Oct. 29 online issue ...
... CRP may only reflect existing cardiovascular trouble, study finds ... levels of C-reactive protein do not increase the ... suggests. , The inflammation-linked molecule has gained prominence in ... But the question remained -- does the protein only ...
... Preliminary results from U.S.,Department of Defense-funded clinical trials ... rooms are contaminated with high levels of,potentially dangerous ... the Interscience Conference on Antimicrobial Agents and Chemotherapy,(ICAAC) ... that objects in,closest proximity to patients, such as ...
... 29 Texcel, a leading,provider of custom ... its innovative new StimX programmable, implantable,stimulation system., ... and development of specialty,stimulation therapies, the StimX ... platform., The StimX system,s programmable stimulation ...
... Rochester NY Growth Company, boasts premiere pharmacy services innovation. ... ... 2008 -- PharmaSmart International , an innovative health management ... levels, worksites, medical facilities and specialty care centers boasts an ...
... to the gym on a regular basis right after a ... the gym one day, then the next day and the ... that the negative effects of skipping exercise can occur in ... to a sedentary lifestyle can quickly lead to symptoms of ...
Cached Medicine News:Health News:Other Health Problems Can Delay MS Diagnosis 2Health News:Key Blood Test Protein May Not Cause Heart Disease 2Health News:Key Blood Test Protein May Not Cause Heart Disease 3Health News:First Results from Hospital Trials Show Pathogens Stay Close to Patients 2Health News:Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies 2Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 2Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 3Health News:PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services 4Health News:New study indicates that exercise prevents fatty liver disease 2
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... is equipped with a new 1/2" Progressive ... excellent sensitivity (1280 (H) x 960 (V) ... uncompressed, high-resolution, digital color images and features ... an exposure range from 1/100,000 to 17.5 ...
... DP70 brings you the latest in imaging technology ... The DP70 offers high resolution, high sensitivity, and ... demanding applications, including fluorescence. CCD ... Bit Depth - 36-bit ...
4 megapixel zoom digicam with a 4x optical zoom, Effective pixels:4.0 million CCD:1/1.8-in. type (4.13 million total pixels), Max Image size:2272 (2,272 x 1,704 pixels), Lens:4x Zoom-Nikkor; f = 7.85...
... superb stand-alone digital camera with networking capability ... or remote locations. Image acquisition and camera ... operates independently or attaches directly to a ... to capture and transfer images. Sharing images ...
Medicine Products: